Dipivefrin hydrochloride is a beta-adrenergic agonist prodrug primarily indicated for the management of intraocular pressure in patients with chronic open-angle glaucoma. As an ophthalmic solution, this… Read more
Dipivefrin hydrochloride is a beta-adrenergic agonist prodrug primarily indicated for the management of intraocular pressure in patients with chronic open-angle glaucoma. As an ophthalmic solution, this medication functions by enhancing the outflow of aqueous humor through the trabecular meshwork. To support rigorous analytical testing and quality control protocols, this category offers a comprehensive selection of Dipivefrin hydrochloride reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. Additionally, stable isotope-labelled compounds are available to assist laboratories in conducting precise impurity profiling, method validation, and pharmacokinetic studies. These high-quality reference materials are essential for ensuring accurate quantification and characterization of the drug substance and its degradation products throughout the lifecycle of pharmaceutical development and manufacturing.